# Pharmacokinetic Study of ADVATE Reconstituted in 2 mL Sterile Water for Injection

> **NCT00952822** · PHASE1 · COMPLETED · sponsor: **Baxalta now part of Shire** · enrollment: 52 (actual)

## Conditions studied

- Hemophilia A

## Interventions

- **BIOLOGICAL:** Antihemophilic factor, recombinant, manufactured protein-free (rAHF-PFM). (Antihemophilic factor is also known as Factor VIII)

## Key facts

- **NCT ID:** NCT00952822
- **Lead sponsor:** Baxalta now part of Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08-08
- **Primary completion:** 2009-10-23
- **Final completion:** 2009-10-23
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2021-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00952822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00952822, "Pharmacokinetic Study of ADVATE Reconstituted in 2 mL Sterile Water for Injection". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00952822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*